Diabetes, infection risk and COVID-19

2017 2017, 2. Classification and diagnosis of diabetes, Diabetes Care, 40, S11, 10.2337/dc17-S005 Beckman, 2016, Vascular complications of diabetes, Circulation Research, 118, 1771, 10.1161/CIRCRESAHA.115.306884 Iglay, 2016, Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus, Current Medical Research and Opinion, 32, 1243, 10.1185/03007995.2016.1168291 Long, 2011, Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection, Journal of Clinical Hypertension, 13, 244, 10.1111/j.1751-7176.2011.00434.x Fazeli Farsani, 2015, Chronic comorbidities in children with type 1 diabetes: a population-based cohort study, Archives of Disease in Childhood, 100, 763, 10.1136/archdischild-2014-307654 Laing, 2003, Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes, Stroke, 34, 418, 10.1161/01.STR.0000053843.03997.35 Critchley, 2018, Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study, Diabetes Care, 41, 2127, 10.2337/dc18-0287 Hine, 2017, Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study, Diabetic Medicine, 34, 551, 10.1111/dme.13205 Kornum, 2007, Type 2 diabetes and pneumonia outcomes: a population-based cohort study, Diabetes Care, 30, 2251, 10.2337/dc06-2417 Mor, 2017, Impact of glycemic control on risk of infections in patients with type 2 diabetes: a population-based cohort study, American Journal of Epidemiology, 186, 227, 10.1093/aje/kwx049 Rao Kondapally Seshasai, 2011, Diabetes mellitus, fasting glucose, and risk of cause-specific death, New England Journal of Medicine, 364, 829, 10.1056/NEJMoa1008862 Carey, 2018, Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study, Diabetes Care, 41, 513, 10.2337/dc17-2131 Allard, 2010, Diabetes and the severity of pandemic influenza A (H1N1) infection, Diabetes Care, 33, 1491, 10.2337/dc09-2215 Jain, 2009, Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009, New England Journal of Medicine, 361, 1935, 10.1056/NEJMoa0906695 Peleg, 2007, Common infections in diabetes: pathogenesis, management and relationship to glycaemic control, Diabetes Metabolism Research Review, 23, 3, 10.1002/dmrr.682 Wang, 2011, Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia, BMC Infectious Diseases, 11, 104, 10.1186/1471-2334-11-104 Wilking, 2010, Mortality of 2009 pandemic influenza A(H1N1) in Germany, Euro Surveillance, 15 Muller, 2005, Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus, Clinical Infectious Diseases, 41, 281, 10.1086/431587 Shah, 2003, Quantifying the risk of infectious diseases for people with diabetes, Diabetes Care, 26, 510, 10.2337/diacare.26.2.510 Forbes, 2013, Mechanisms of diabetic complications, Physiological Reviews, 93, 137, 10.1152/physrev.00045.2011 Anhê, 2020, Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity, Nature Metabolism, 2, 233, 10.1038/s42255-020-0178-9 Thaiss, 2018, Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection, Science, 359, 1376, 10.1126/science.aar3318 Alexandraki, 2008, Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation, Journal of Clinical Immunology, 28, 314, 10.1007/s10875-007-9164-1 Davidson, 1984, Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins, Journal of Clinical Pathology, 37, 783, 10.1136/jcp.37.7.783 Delamaire, 1997, Impaired leucocyte functions in diabetic patients, Diabetic Medicine, 14, 29, 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V Huang, 2019, Distinct neutrophil counts and functions in newly diagnosed type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes, Diabetes Metabolism Research Review, 35, 10.1002/dmrr.3064 Lecube, 2011, Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement, PloS One, 6, 10.1371/journal.pone.0023366 Marhoffer, 1992, Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes, Diabetes Care, 15, 256, 10.2337/diacare.15.2.256 Mowat, 1971, Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis, Journal of Clinical Investigation, 50, 2541, 10.1172/JCI106754 Pavlou, 2018, Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity, BMC Immunology, 19, 24, 10.1186/s12865-018-0261-0 Spiller, 2012, alpha1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice, Diabetes, 61, 1584, 10.2337/db11-0825 Tater, 1987, Polymorphonuclear cell derangements in type I diabetes, Hormone and Metabolic Research, 19, 642, 10.1055/s-2007-1011899 Trevelin, 2017, Diabetes mellitus and sepsis: a challenging association, Shock, 47, 276, 10.1097/SHK.0000000000000778 Lederman, 1981, Pneumococcal immunization in adult diabetics, Diabetes, 30, 119, 10.2337/diab.30.2.119 Li Volti, 1998, Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus, Archives of Disease in Childhood, 78, 54, 10.1136/adc.78.1.54 Pozzilli, 1986, The immune response to influenza vaccination in diabetic patients, Diabetologia, 29, 850, 10.1007/BF00870139 Sheridan, 2015, The antibody response to influenza vaccination is not impaired in type 2 diabetics, Vaccine, 33, 3306, 10.1016/j.vaccine.2015.05.043 Bahr, 2018, Impaired natural killer cell subset phenotypes in human obesity, Immunologic Research, 66, 234, 10.1007/s12026-018-8989-4 Kim, 2019, Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes, Journal of Diabetes Investigation, 10, 1223, 10.1111/jdi.13002 Boutens, 2016, Adipose tissue macrophages: going off track during obesity, Diabetologia, 59, 879, 10.1007/s00125-016-3904-9 Lumeng, 2008, Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes, Diabetes, 57, 3239, 10.2337/db08-0872 Kratz, 2014, Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages, Cell Metabolism, 20, 614, 10.1016/j.cmet.2014.08.010 Huang, 2016, Neutrophils in type 1 diabetes, Journal of Diabetes Investigation, 7, 652, 10.1111/jdi.12469 Collier, 1989, Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus, Diabetes Research, 10, 135 Harsunen, 2013, Reduced blood leukocyte and neutrophil numbers in the pathogenesis of type 1 diabetes, Hormone and Metabolic Research, 45, 467, 10.1055/s-0032-1331226 Valle, 2013, Reduction of circulating neutrophils precedes and accompanies type 1 diabetes, Diabetes, 62, 2072, 10.2337/db12-1345 Inacio, 2018, Control of T cell effector functions by miRNAs, Cancer Letters, 427, 63, 10.1016/j.canlet.2018.04.011 Stentz, 2003, Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies, Current Drug Targets, 4, 493, 10.2174/1389450033490966 Nicholas, 2019, Fatty acid metabolites combine with reduced beta oxidation to activate Th17 inflammation in human type 2 diabetes, Cell Metabolism, 30, 447, 10.1016/j.cmet.2019.07.004 Pradhan, 2001, C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, Journal of the American Medical Association, 286, 327, 10.1001/jama.286.3.327 Garidou, 2015, The gut microbiota regulates intestinal CD4 T cells expressing RORgammat and controls metabolic disease, Cell Metabolism, 22, 100, 10.1016/j.cmet.2015.06.001 Menart-Houtermans, 2014, Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS), Diabetes Care, 37, 2326, 10.2337/dc14-0316 Nishimura, 2009, CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity, Nature Medicine, 15, 914, 10.1038/nm.1964 Jagannathan-Bogdan, 2011, Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes, The Journal of Immunology, 186, 1162, 10.4049/jimmunol.1002615 Sireesh, 2018, Association of NF-E2 related factor 2 (Nrf2) and inflammatory cytokines in recent onset type 2 diabetes mellitus, Scientific Reports, 8, 5126, 10.1038/s41598-018-22913-6 Cortez-Espinosa, 2015, CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes, Human Immunology, 76, 622, 10.1016/j.humimm.2015.09.007 Tang, 2008, Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction, Immunity, 28, 687, 10.1016/j.immuni.2008.03.016 Xufre, 2013, Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients, International Immunology, 25, 563, 10.1093/intimm/dxt020 Woo, 2010, Coronavirus genomics and bioinformatics analysis, Viruses, 2, 1804, 10.3390/v2081803 de Wilde, 2018, Host factors in coronavirus replication, Current Topics in Microbiology and Immunology, 419, 1 Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8 Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058 Raj, 2013, Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC, Nature, 495, 251, 10.1038/nature12005 Chan-Yeung, 2003, SARS: epidemiology, Respirology, 8, S9, 10.1046/j.1440-1843.2003.00518.x World Health Organization, 2019 World Health Organization, 2020 Tay, 2020, The trinity of COVID-19: immunity, inflammation and intervention, Nature Reviews Immunology, 10.1038/s41577-020-0311-8 Kim, 2020, Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea, Journal of Korean Medical Science, 35, e86, 10.3346/jkms.2020.35.e86 Pan, 2020, Viral load of SARS-CoV-2 in clinical samples, The Lancet Infectious Diseases, 20, 411, 10.1016/S1473-3099(20)30113-4 Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5 Zou, 2020, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, New England Journal of Medicine, 382, 1177, 10.1056/NEJMc2001737 Ling, 2020, Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings, European Journal of Radiology, 126, 108956, 10.1016/j.ejrad.2020.108956 Badawi, 2016, Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis, International Journal of Infectious Diseases, 49, 129, 10.1016/j.ijid.2016.06.015 Booth, 2003, Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area, Journal of the American Medical Association, 289, 2801, 10.1001/jama.289.21.JOC30885 Hui, 2018, Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission, The Lancet Infectious Diseases, 18, e217, 10.1016/S1473-3099(18)30127-0 Rivers, 2016, Risks of death and severe disease in patients with Middle East respiratory syndrome coronavirus, 2012-2015, American Journal of Epidemiology, 184, 460, 10.1093/aje/kww013 Yang, 2017, Impact of comorbidity on fatality rate of patients with Middle East respiratory syndrome, Scientific Reports, 7, 11307, 10.1038/s41598-017-10402-1 Fu, 2020, Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis, Journal of Infection, 10.1016/j.jinf.2020.03.041 Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respiration Medicine, 10.1016/S2213-2600(20)30079-5 Yang, 2006, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS, Diabetic Medicine, 23, 623, 10.1111/j.1464-5491.2006.01861.x Alqahtani, 2018, Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study, Epidemiology and Infection, 1 Zhang, 2020, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy, 10.1111/all.14238 Li, 2020, Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China, Clinical Research in Cardiology, 109, 531, 10.1007/s00392-020-01626-9 Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention, Journal of the American Medical Association, 10.1001/jama.2020.2648 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area, Journal of the American Medical Association, 10.1001/jama.2020.6775 Zhu, 2020, Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes, Cell Metabolism, 31, 1068, 10.1016/j.cmet.2020.04.021 Holman, 2020 Caussy, 2020, Prevalence of obesity among adult inpatients with COVID-19 in France, Lancet Diabetes Endocrinology, 10.1016/S2213-8587(20)30160-1 Lighter, 2020, Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission, Clinical Infectious Diseases, 10.1093/cid/ciaa415 Kass, 2020, Obesity could shift severe COVID-19 disease to younger ages, Lancet, 395, 1544, 10.1016/S0140-6736(20)31024-2 Docherty, 2020, Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study, BMJ, 369, m1985, 10.1136/bmj.m1985 Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clinical and Experimental Immunology, 136, 95, 10.1111/j.1365-2249.2004.02415.x Shi, 2020, COVID-19 infection: the perspectives on immune responses, Cell Death & Differentiation, 27, 1451, 10.1038/s41418-020-0530-3 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, Journal of the American Medical Association, 10.1001/jama.2020.1585 Chen, 2020, Clinical and immunological features of severe and moderate coronavirus disease 2019, Journal of Clinical Investigation, 10.1172/JCI137244 Pedersen, 2020, SARS-CoV-2: a storm is raging, Journal of Clinical Investigation, 10.1172/JCI137647 Channappanavar, 2016, Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice, Cell Host & Microbe, 19, 181, 10.1016/j.chom.2016.01.007 Liu, 2020, Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients, EBioMedicine, 55, 102763, 10.1016/j.ebiom.2020.102763 Kulcsar, 2019, Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection, JCI Insight, 4, 10.1172/jci.insight.131774 Marshall, 2020, Glycemic variability in diabetes increases the severity of influenza, mBio, 11, 10.1128/mBio.02841-19 Monteil, 2020, Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell, 10.1016/j.cell.2020.04.004 Roca-Ho, 2017, Characterization of ACE and ACE2 expression within different organs of the NOD mouse, International Journal of Molecular Sciences, 18, 10.3390/ijms18030563 Drucker, 2020, Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications, Endocrine Reviews, 41, 10.1210/endrev/bnaa011 Philips, 2003, Factors determining the appearance of glucose in upper and lower respiratory tract secretions, Intensive Care Medicine, 29, 2204, 10.1007/s00134-003-1961-2 Kohio, 2013, Glycolytic control of vacuolar-type ATPase activity: a mechanism to regulate influenza viral infection, Virology, 444, 301, 10.1016/j.virol.2013.06.026 Reading, 1998, Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose?, Journal of Virology, 72, 6884, 10.1128/JVI.72.8.6884-6887.1998 Darvishi-Khezri, 2016, Is type 2 diabetes mellitus in mechanically ventilated adult trauma patients potentially related to the occurrence of ventilator-associated pneumonia?, Journal of Research in Medical Sciences, 21, 19, 10.4103/1735-1995.179887 Anandhalakshmi, 2013, Alveolar gas exchange and pulmonary functions in patients with type II diabetes mellitus, Journal of Clinical and Diagnostic Research, 7, 1874 Komatsu, 2010, Aerobic exercise capacity and pulmonary function in athletes with and without type 1 diabetes, Diabetes Care, 33, 2555, 10.2337/dc10-0769 Popov, 1997, Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters, European Respiratory Journal, 10, 1850, 10.1183/09031936.97.10081850 Weynand, 1999, Diabetes mellitus induces a thickening of the pulmonary basal lamina, Respiration, 66, 14, 10.1159/000029331 Chen, 2019, Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome, Frontiers in Microbiology, 10, 50, 10.3389/fmicb.2019.00050 Wang, 2020, Comorbidities and multi-organ injuries in the treatment of COVID-19, Lancet, 395, 10.1016/S0140-6736(20)30558-4 Varga, 2020, Endothelial cell infection and endotheliitis in COVID-19, Lancet, 395, 1417, 10.1016/S0140-6736(20)30937-5 Avogaro, 2011, Endothelial dysfunction in diabetes: the role of reparatory mechanisms, Diabetes Care, 34, S285, 10.2337/dc11-s239 Hulme, 2017, Influenza virus and glycemic variability in diabetes: a killer combination?, Frontiers in Microbiology, 8, 861, 10.3389/fmicb.2017.00861 Perrone, 2008, H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice, PLoS Pathogens, 4, 10.1371/journal.ppat.1000115 Short, 2014, Pathogenesis of influenza-induced acute respiratory distress syndrome, The Lancet Infectious Diseases, 14, 57, 10.1016/S1473-3099(13)70286-X Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, Journal of Thrombosis and Haemostasis, 18, 844, 10.1111/jth.14768 Cui, 2020, Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia, Journal of Thrombosis and Haemostasis, 10.1111/jth.14830 Klok, 2020, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thrombosis Research Antoniak, 2018, The coagulation system in host defense, Research Practitioner Thrombosis & Haemostasis, 2, 549, 10.1002/rth2.12109 Carr, 2001, Diabetes mellitus: a hypercoagulable state, Journal of Diabetic Complications, 15, 44, 10.1016/S1056-8727(00)00132-X Kearney, 2017, Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk, Cardiovascular Diabetology, 16, 34, 10.1186/s12933-017-0515-9 Stegenga, 2008, Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia, Blood, 112, 82, 10.1182/blood-2007-11-121723